Target intelligence / Profile preview

Beta-defensin 114 (DEFB114)

Target
DEFB114
Molecular classification
Antimicrobial peptide, Beta-defensin family, Secreted protein
01

Overview

Beta-defensin 114 (DEFB114) is a member of the beta-defensin family, which comprises short, cationic antimicrobial peptides involved in the innate immune response. DEFB114 is encoded by the DEFB114 gene, and its protein product displays salt-sensitive antimicrobial activity against Gram-negative bacteria (e.g., *Escherichia coli*), Gram-positive bacteria (e.g., *Staphylococcus aureus*), and fungi (e.g., *Candida albicans*). Functionally, DEFB114 binds and neutralizes bacterial lipopolysaccharide (LPS), thereby reducing LPS-induced tumor necrosis factor (TNF) production by macrophages and counteracting the negative effects of LPS on sperm motility. This defensin is part of the densely clustered beta-defensin gene loci in the human genome and may play roles in infection, inflammation, and male reproductive health.

Other names
Beta-defensin 114DEFB114DEFB14DEFB-14Beta-defensin 14Defensin, beta 114beta-defensin 114defensin, beta 14
02

Mechanism of action

Not applicable; no drugs directly targeting DEFB114 are documented

03

Biological functions

Antimicrobial activity (against Gram-negative and Gram-positive bacteria and fungi)Lipopolysaccharide binding and neutralizationModulation of inflammatory responseProtection of sperm motility in response to endotoxininnate immune defense
04

Disease associations

InfectionInflammationMale reproductive dysfunction (e.g., salpingo-oophoritis)

Beyond the preview

Go deeper on Beta-defensin 114 (DEFB114).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-defensin 114 (DEFB114).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call